Wells Fargo Initiates Coverage On ALX Oncology Holdings with Overweight Rating, Announces Price Target of $5

ALX Oncology Holdings

ALX Oncology Holdings

ALXO

0.00

Wells Fargo analyst Derek Archila initiates coverage on ALX Oncology Holdings (NASDAQ: ALXO) with a Overweight rating and announces Price Target of $5.